• Q&A: Where are we in the COVID-19 vaccine race?
    NEW YORK (Reuters) - Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. As some companies close in on unveiling their initial findings - with Canadian and European regulators already reviewing early data on some vaccines - the following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed
  • WHO vaccine drive bedevilled by familiar question: who pays if things go wrong?
    BRUSSELS, October 15 (Reuters) - Who foots the bill if people in poor countries fall sick with unexpected side-effects from coronavirus vaccines? It's not clear and that's a big problem in the battle to beat COVID-19. The World Health Organization (WHO) has so far left the question of financial claims unresolved as it seeks to ensure shots are fairly distributed around the world, according to confidential documents reviewed by Reuters and six people familiar with discussions
  • Pak hopeful of acquiring Covid-19 vaccine within the next 6 months
    Islamabad, October 12 (IANS): A Pakistani official from the Ministry of National Health Services has expressed hope that the country would acquire a vaccine against the novel coronavirus in the next six months. The official said on Sunday that Pakistan has also prepared antibodies against spike proteins, Dawn news reported. "At present, 15 vaccines were in phase-III trial globally out of which 11 target the spike protein," he said. The official said the vaccine might
  • 'Work risk, disease severity to be factors in vaccine dispensing'
    New Delhi, October 11 (IANS) The government would look at two key considerations for prioritisation of the Covid-19 vaccine -- the occupational hazard and risk of exposure to infection, and secondly, the risk of developing severe disease and increased mortality, Union Health Minister Harsh Vardhan said on Sunday. Besides, the supply of vaccines is anticipated to be available in limited quantities in the beginning, he added, during 'Sunday Samvaad', a weekly webinar which he
  • India to have coronavirus vaccine by 2020 end: Harsh Vardhan
    New Delhi, August 22 (IANS): Union Minister of Health and Family Welfare Harsh Vardhan said on Saturday that the country will have a vaccine against the deadly coronavirus by the end of the year. Speaking to reporters here, he said that a Covid-19 vaccine is likely in the next 4-5 months. "I hope that if everything goes well, India will have access to a coronavirus vaccine by the end of 2020," the minister tweeted later. The Ministry of Health and Family Welfare said
  • Russia becomes first country to approve a COVID-19 vaccine, says Putin
    MOSCOW, August 11 (Reuters): President Vladimir Putin said on Tuesday that Russia had become the first country in the world to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess. The development paves the way for the mass inoculation of the Russian population, even as the final stage of clinical trials to test safety and efficacy continue.    The speed at which R
  • Wockhardt wins UK govt deal on Covid-19 vaccine manufacturing
    Mumbai, Augùst 3 (IANS) Mumbai-headquartered pharmaceutical company Wockhardt on Monday announced that it has entered into an agreement with the UK government to fill-finish millions of doses of Covid-19 vaccines. As per the terms of the agreement, the company has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK government in its fight against Covid-19, including AZD1222, the vaccine co-invented by the University of Oxford and its spin-ou
  • Russia 1st nation to finish human trials for Covid-19 vaccine
    Moscow, July 12 (IANS) Russia has become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have proven the medication's effectiveness, the media reported on Sunday.   Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University, told Russian news agency TASS on Sunday that the human trials for the vaccine have been completed at the university and they will be discharged soon
  • 'Aug 15 for COVID-19 vaccine launch unfeasible'
    New Delhi, July 6 (PTI): The Indian Academy of Sciences, a Bengaluru-based body of scientists, has said the Indian Council for Medical Research's  target to launch a coronavirus vaccine by August 15 is "unfeasible" and "unrealistic".   The IASc said while there is an unquestioned urgent need, vaccine development for use in humans requires scientifically executed clinical trials in a phased manner.   While administrative approvals can b